-
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
Disability Resource Utilization and Caregiver Support Among a Real-World Sample of Patients With Transthyretin Amyloidosis With Polyneuropathy
Sep 9, 2025, 16:22 PM -
Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
A Review of Information Uncertainty in Oncology Treatment Preferences
Sep 9, 2025, 16:22 PM -
Tracing the Shift in Payer Evidence Expectations: A Review of AMCP Format Updates (2016-2024)
Sep 9, 2025, 16:22 PM -
Science at PACE? A Multi-Stakeholder Developed Framework for Accelerated Patient Access to Cancer Care
Sep 9, 2025, 16:22 PM -
Integrating CEUS in Diagnostic Pathways: Evidence of Economic and Organizational Sustainability From the Italian Healthcare System
Sep 9, 2025, 16:22 PM -
Development of a Discrete Choice Experiment Survey to Assess Patient Preferences for Treatment of Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials
Sep 9, 2025, 16:22 PM -
Understanding Heterogeneity in the Classification of Locally Advanced Cancer: Analysis of Clinical Trial Records From the Past 2 Years (2023-2025)
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life of Patients With Epidermolysis Bullosa in Hungary: Results With the EQ-5D-5L and EQ-5D-Y-3L Preference-Based Measurement Tools
Sep 9, 2025, 16:22 PM -
Quantifying the Impact of Data Digital and AI on Health Systems
Sep 9, 2025, 16:22 PM -
Evolution of Manufacturer-Set List Prices and GKV Rebates for Orphan Drugs (OD) in Germany 2013-2024: How Much US WAC Is in German OD-Prices
Sep 9, 2025, 16:22 PM -
Economic Burden of Systemic Lupus Erythematosus (SLE) Among Women in the USA: A Systematic Review
Sep 9, 2025, 16:22 PM -
Comparative Cardiovascular Safety of Romosozumab and Denosumab in Osteoporosis Treatment: A Multinational Real-World Cohort Study
Sep 9, 2025, 16:22 PM -
Air Pollution Signals and National Demand for Asthma Medication in Brazil Between 2018-2023: Should It Be Considered a Public-Health Concern?
Sep 9, 2025, 16:22 PM -
Ensuring Patient Inclusion When Baseline Is Missing: Utilizing Constrained Longitudinal Data Analysis (cLDA) for Patient-Reported Outcomes (PROs)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Evaluation of RSVpreF Vaccine for Preventing RSV Among Older Adults With High Risk Under Taiwan National Vaccination Program
Sep 9, 2025, 16:22 PM -
Cost of First-Line Treatment of Hepatocellular Carcinoma With the Immune Checkpoint Inhibitor-Based Regimens STRIDE and Atezolizumab Plus Bevacizumab in Brazil
Sep 9, 2025, 16:22 PM -
External Control Arm for PHAROS Trial Patients With Metastatic BRAF V600e Mutated NSCLC Treated With First-Line Encorafenib Plus Binimetinib Using Real-World Data From the French ESME Lung Cancer Database (ERASME STUDY)
Sep 9, 2025, 16:22 PM
